Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BioElectronics Corporation (BIEL) Message Board

Strategic Path Forward for BIEL + Partner(s) Mate

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 8896
(Total Views: 239)
Posted On: 11/18/2025 8:34:29 PM
Posted By: Bielionaire
Strategic Path Forward for BIEL + Partner(s)
Material Nonpublic Information (MNPI): If Electrome.io—or any partner—holds MNPI through ongoing negotiations or privileged access, trading is strictly prohibited. That’s a hard legal line. However, if no MNPI is involved, open‑market accumulation is entirely permissible, subject to beneficial ownership reporting thresholds and any contractual restrictions. Outside partners without MNPI can buy freely.

Insider Convertible Notes & Share Availability:

Authorized Shares Constraint: With the authorized share count fully allocated, insiders cannot convert notes until additional capacity is created—typically via a reverse split or an increase in authorized shares.

Alternative Path: Importantly, these notes don’t need to be converted to transfer value. They can be sold as notes (i.e., debt instruments), enabling a stake transfer without issuing new equity immediately.

Strategic Benefit: This preserves insiders’ upside on the bulk of their holdings while bypassing the immediate authorized‑share bottleneck.

Strategic Move for Electrome.io (and Partners): A more forward‑thinking play would be for Electrome.io (and/or other partners) to acquire a stake in BIEL now and ride the exponential upside as the PPS continues to rise. This can be executed immediately:

Via the open market (if no MNPI is in play).

Or through insiders selling a small portion of their notes as debt instruments.

Either route provides immediate exposure without waiting for a reverse split. Insiders would still stand to become enormously wealthy from their remaining notes, while partners gain early positioning in a rising PPS environment.



(2)
(0)




BioElectronics Corporation (BIEL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us